AquaBounty Technologies (AQB) and Its Peers Head-To-Head Survey

AquaBounty Technologies (NASDAQ:AQB) is one of 844 public companies in the “Biotechnology” industry, but how does it weigh in compared to its rivals? We will compare AquaBounty Technologies to similar companies based on the strength of its dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Risk & Volatility

AquaBounty Technologies has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500. Comparatively, AquaBounty Technologies’ rivals have a beta of 1.10, indicating that their average share price is 10% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent recommendations and price targets for AquaBounty Technologies and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AquaBounty Technologies	1	0	0	0	1.00
AquaBounty Technologies Competitors	9838	15122	45436	1587	2.54

As a group, “Biotechnology” companies have a potential upside of 102.62%. Given AquaBounty Technologies’ rivals stronger consensus rating and higher probable upside, analysts clearly believe AquaBounty Technologies has less favorable growth aspects than its rivals.

Institutional and Insider Ownership

8.9% of AquaBounty Technologies shares are held by institutional investors. Comparatively, 47.9% of shares of all “Biotechnology” companies are held by institutional investors. 1.0% of AquaBounty Technologies shares are held by insiders. Comparatively, 12.9% of shares of all “Biotechnology” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares AquaBounty Technologies and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
AquaBounty Technologies	$2.47 million	-$18.49 million	-1.19
AquaBounty Technologies Competitors	$701.44 million	$12.42 million	-15.18

AquaBounty Technologies’ rivals have higher revenue and earnings than AquaBounty Technologies. AquaBounty Technologies is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares AquaBounty Technologies and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AquaBounty Technologies	N/A	-147.07%	-35.44%
AquaBounty Technologies Competitors	-12,346.73%	-197.60%	-30.56%

Summary

AquaBounty Technologies rivals beat AquaBounty Technologies on 9 of the 12 factors compared.

About AquaBounty Technologies

AquaBounty Technologies, Inc., a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Harvard, Massachusetts.